REGENERON PHARMACEUTICALS, INC. Deferred Revenue
REGENERON PHARMACEUTICALS, INC. (REGN) had Deferred Revenue of $160.47 million as of 2018-03-31, per its 10-Q filed 2018-05-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-05-03
- 2018-03-31: Deferred Revenue, Current $160.47M.
- 2017-12-31: Deferred Revenue, Current $142.39M; Deferred Revenue, Current as first filed $320.14M.
- 2017-09-30: Deferred Revenue, Current $132.83M.
- 2017-06-30: Deferred Revenue, Current $127.80M.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2018-03-31 | $160.47M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $142.39M 10-Q · filed 2018-05-03 | $320.14M 10-K · filed 2018-02-08 |
| 2017-09-30 | $132.83M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $127.80M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $126.26M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $231.66M 10-K · filed 2018-02-08 | |
| 2016-09-30 | $137.64M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $84.08M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $73.63M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $153.49M 10-K · filed 2017-02-09 | |
| 2015-09-30 | $54.15M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $51.72M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $51.84M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $74.03M 10-K · filed 2016-02-11 | |
| 2014-09-30 | $57.60M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $54.15M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $53.09M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $47.00M 10-K · filed 2015-02-12 | |
| 2013-09-30 | $34.93M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $34.27M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $34.39M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $50.83M 10-K · filed 2014-02-13 | |
| 2012-09-30 | $33.48M 10-Q · filed 2012-10-24 | |
| 2011-12-31 | $51.64M 10-K · filed 2013-02-15 | |
| 2011-09-30 | $33.61M 10-Q · filed 2011-10-27 | |
| 2011-06-30 | $33.61M 10-Q · filed 2011-07-28 | |
| 2011-03-31 | $33.29M 10-Q · filed 2011-05-03 | |
| 2010-12-31 | $54.72M 10-K · filed 2012-02-21 | $35.22M 10-K · filed 2011-02-17 |
| 2010-09-30 | $38.89M 10-Q · filed 2010-10-28 | |
| 2010-06-30 | $41.74M 10-Q · filed 2010-07-28 | |
| 2009-12-31 | $27.02M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |